We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Yale School of Medicine, New Haven, CT, USA
Dr Anne Chiang is an associate professor of medicine in the section of Medical Oncology and the Associate Cancer Center Director, Clinical Initiatives, both at Yale School of Medicine in Connecticut, USA. read more
Dr Chiang has a background in translational research in metastasis, as well as extensive experience in clinical practice in both academic and community settings. She specializes in thoracic oncology and her clinical focus has been on building a small cell lung cancer programme at Yale, with a comprehensive portfolio of clinical trials testing novel therapeutics for these patients. Her research interests focus on the development of clinical trials and translational studies to test novel agents and combinations with immune checkpoint inhibitors, for both small cell and non-small cell lung tumours.
Dr Chiang has served as Deputy Chief Medical Officer and Chief Integration Officer for Smilow Cancer Hospital (SCH), having helped to build the SCH Network and oversee operations, quality efforts and clinical research in 15 Smilow Care Centers. She has a particular focus on quality measurement and improvement and has spearheaded quality initiatives locally and nationally for the American Society of Clinical Oncology.
Dr Anne Chiang discloses: Advisory board or panel fees from AstraZeneca, Daiichi Sankyo, Genentech and Janssen. Grants/research support from AbbVie, Amgen, Bristol Myers Squibb and Genentech.